Prediction of survival outcomes in NSCLC using a new PRO index from the LCSS (Lung Cancer Symptom Scale): Results of a 622-patient prospective trial.
Richard J. Gralla
Research Funding - Sanofi
Patricia J Hollen
Research Funding - Sanofi
Sumitra Thongprasert
No relevant relationships to disclose
Hoon-Kyo Kim
No relevant relationships to disclose
Te-Chun Hsia
No relevant relationships to disclose
Shi Yuankai
No relevant relationships to disclose
Nina Kohn
No relevant relationships to disclose
Martin Lesser
No relevant relationships to disclose